Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies
暂无分享,去创建一个
Mark S. Anderson | Christopher S. Law | J. Derisi | I. Noth | M. Strek | P. Wolters | V. Upadhyay | R. Guzy | A. Sperling | M. Clark | A. Shum | A. Adegunsoye | J. DeRisi | D. Decker | K. Blaine | Y. Yoon | S. Vazquez | C. T. Lee | Cathryn T. Lee | A. Shum | V. Upadhyay | T. Velez | Y. Yoon | M. S. Anderson | C. S. Law | K. Selvan | M. K. Hollinger | M. Stręk | K.C. Selvan
[1] Mark S. Anderson,et al. PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung disease , 2023, bioRxiv.
[2] D. Farber,et al. Inhaled particulate accumulation with age impairs immune function and architecture in human lung lymph nodes , 2022, Nature Medicine.
[3] F. Martinez,et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2022, American journal of respiratory and critical care medicine.
[4] G. Qian,et al. PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways , 2022, Scientific Reports.
[5] Hyun J. Kim,et al. Hospitalizations in patients with idiopathic pulmonary fibrosis , 2021, Respiratory Research.
[6] J. Craft,et al. T Follicular Regulatory Cells: Choreographers of Productive Germinal Center Responses , 2021, Frontiers in Immunology.
[7] N. Kaminski,et al. The Idiopathic Pulmonary Fibrosis Cell Atlas. , 2020, American journal of physiology. Lung cellular and molecular physiology.
[8] M. González-Gay,et al. Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review , 2020, Journal of clinical medicine.
[9] Jonathan H. Chung,et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline , 2020, American journal of respiratory and critical care medicine.
[10] Mark S. Anderson,et al. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display , 2020, Brain communications.
[11] R. Kaarteenaho,et al. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases , 2020, PloS one.
[12] Mark S. Anderson,et al. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq , 2020, eLife.
[13] Mohammed I. Alghamdi,et al. An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders , 2019, Journal of immunology research.
[14] M. Kool,et al. Enhanced Bruton’s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis , 2019, Respiratory Research.
[15] Jungsun Lee,et al. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis. , 2019, Respiratory medicine.
[16] E. Wherry,et al. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.
[17] Jonathan H. Chung,et al. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation , 2019, American journal of respiratory and critical care medicine.
[18] I. Noth,et al. T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival , 2019, Respiratory medicine: X.
[19] Takeshi Johkoh,et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[20] Y. Yamaguchi,et al. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion , 2018, Journal of cellular physiology.
[21] Lin Sun,et al. Deficiency in T follicular regulatory cells promotes autoimmunity , 2018, The Journal of experimental medicine.
[22] A. Fischer,et al. Lung Disease in Rheumatoid Arthritis , 2018, Respiratory Medicine.
[23] G. Raghu,et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? , 2018, The Lancet. Respiratory medicine.
[24] I. Noth,et al. ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s , 2017, Mucosal Immunology.
[25] Q. Ye,et al. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis , 2017, Respiratory Research.
[26] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[27] N. Frangogiannis,et al. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[28] I. Noth,et al. Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function , 2016, Front. Immunol..
[29] J. Ryu. Faculty of 1000 evaluation for An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. , 2016 .
[30] J. Cesbron,et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry , 2016, PloS one.
[31] D. Lynch,et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.
[32] M. Saul,et al. Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2015, PloS one.
[33] J. Golden,et al. Lung transplantation for hypersensitivity pneumonitis. , 2015, Chest.
[34] I. Nishino,et al. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1 , 2015, Genes to cells : devoted to molecular & cellular mechanisms.
[35] Josef Stehlik,et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[36] Zora Modrusan,et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis , 2014, Thorax.
[37] J. Leader,et al. C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.
[38] D. Bruzzese,et al. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients. , 2014, Cytokine.
[39] George C Tseng,et al. Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis , 2013, Science Translational Medicine.
[40] A. Burke,et al. Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis , 2013, Journal of inflammation research.
[41] H. Collard,et al. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. , 2013, Respiratory medicine.
[42] P. López,et al. Effects of glucocorticoid treatment on CD25⁻FOXP3⁺ population and cytokine-producing cells in rheumatoid arthritis. , 2012, Rheumatology.
[43] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[44] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[45] Carola G. Vinuesa,et al. Foxp3(+) follicular regulatory T cells control the germinal centre response , 2012 .
[46] Uri Laserson,et al. Autoantigen discovery with a synthetic human peptidome. , 2011, Nature biotechnology.
[47] J. Fagius,et al. T regulatory cells lacking CD25 are increased in MS during relapse , 2010, Autoimmunity.
[48] V. Aidinis,et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[49] L. Klareskog,et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells , 2008, Annals of the rheumatic diseases.
[50] P. Lipsky,et al. Clinical significance of increased CD4+CD25−Foxp3+ T cells in patients with new-onset systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.
[51] P. Greenberg,et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.
[52] R. Kairalla,et al. Inflammatory Cell Phenotyping of the Pulmonary Interstitium in Idiopathic Interstitial Pneumonia , 2006, Respiration.
[53] V. Soumelis,et al. Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis1 , 2006, The Journal of Immunology.
[54] Andreas Thiel,et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression , 2005, Nature Medicine.
[55] T. Li,et al. Normal retinal development and retinofugal projections in mice lacking the retina-specific variant of actin-binding lim domain protein , 2003, Neuroscience.
[56] J. Behr. [Diagnosis of idiopathic pulmonary fibrosis]. , 2001, Pneumologie.
[57] Tiansen Li,et al. Molecular Characterization of abLIM, a Novel Actin-binding and Double Zinc Finger Protein , 1997, The Journal of cell biology.
[58] J. Talbott,et al. PULMONARY INVOLVEMENT IN RHEUMATOID ARTHRITIS. , 1964, JAMA.